Cryoglobulinemia and Cryofibrinogenemia
Cryoglobulinemia and cryofibrinogenemia are two rare but particularly serious cold-precipitating blood disorders seen in dermatology. Both involve abnormal proteins in the serum or plasma (monoclonal/polyclonal antibodies or fibrinogen) that reversibly precipitate when body temperature drops below 37°C and dissolve again on rewarming. This precipitation takes place inside the blood vessels themselves, increasing blood viscosity, forming microvascular clots and triggering inflammation of small to medium-sized vessels. In the skin, the result is impaired microcirculation: Raynaud phenomenon, palpable purpura, a dusky net-like mottling (livedo reticularis), hemorrhagic blisters and, ultimately, extremely painful necrotic ulcers on the extremities (fingers, toes, ear rims, tip of the nose). Cryoglobulinemia is closely linked to hepatitis C (HCV) infection, autoimmune diseases (Sjögren syndrome, lupus) or plasma cell disorders, whereas cryofibrinogenemia may be primary or secondary to cancer or infection. At Haute-Derma, we follow a strict blood collection and cryoprotein testing protocol that keeps samples at 37°C, coordinate systemic medical treatment to switch off the autoimmune response, and use advanced wound-healing techniques for necrotic tissue.
How the disease damages the skin and immune system:
- Temperature-Reversible Protein Precipitation and Mechanical Vessel Blockage:
- As skin temperature falls (especially at the extremities), cryoglobulins (complexes of IgA, IgG and IgM immunoglobulins) or cryofibrinogen (complexes of fibrinogen, fibrin and fibronectin) change shape and clump into gel-like or crystalline masses.
- These precipitates physically plug the arterioles and capillaries of the superficial and deep dermis and the subcutis, bringing microcirculatory blood flow to a halt.
- Immune Complex Deposition and Leukocytoclastic Vasculitis (Type II and III Cryoglobulinemia):
- In mixed cryoglobulinemia (types II and III), the cryoglobulins are immune complexes (for example, IgM directed against IgG).
- These complexes settle in the vessel walls, activate the classical complement pathway and attract neutrophils, producing leukocytoclastic vasculitis (LCV) with fibrinoid necrosis of the vessel wall.
- Acute Ischemia and Deep Tissue Necrosis:
- Prolonged ischemia from vessel blockage combined with vasculitis kills endothelial and epidermal cells.
- Substances released from dying tissue trigger secondary inflammation, leading to deep hemorrhagic blisters, sharply demarcated black necrotic ulcers and a risk of dry gangrene of the fingers and toes.
Skin Manifestations of Cold-Precipitating Blood Disorders (Cryo-Immunopathies)
| Clinical sign | What it looks like | Cellular and molecular mechanism |
|---|---|---|
| Palpable purpura | Raised purple-red papules, dots or patches that do not blanch with pressure; mostly on the lower legs and cold-exposed areas. | Deposited cryoglobulin complexes trigger LCV, causing red cells to leak out and the vessel wall to undergo necrosis. |
| Livedo reticularis / racemosa | A net of bluish-purple or deep red streaks following the skin's small vessels; irregular and not fully closed. | Partial blockage of superficial venous/capillary flow from increased viscosity and cold-induced protein precipitation. |
| Hemorrhagic blisters and necrotic ulcers of the extremities | Blood-filled blisters that rupture into deep ulcers with a sharply defined black necrotic base; intensely painful. | Ischemic necrosis of the full epidermis and dermis from complete occlusion of subcutaneous vessels. |
| Raynaud phenomenon and acrocyanosis | Three-phase color change (white, blue-purple, red) or persistent bluish discoloration of the fingers, toes and ear rims in the cold. | Vasospasm combined with cryoprotein precipitation obstructs flow in small peripheral vessels. |
| Cold urticaria | Itchy red wheals that appear quickly where the skin touches cold objects or cold air. | Cryoglobulin precipitation activates mast cells, which release histamine and other mediators that cause dermal swelling. |
Cryoglobulinemia vs. Cryofibrinogenemia
| Feature | Cryoglobulinemia (antibody precipitation) | Cryofibrinogenemia (fibrinogen precipitation) |
|---|---|---|
| Precipitate composition | Immunoglobulins (IgG, IgM, IgA), with or without complement | Fibrinogen, fibrin, fibronectin, factor VIII (no immunoglobulin) |
| Required sample | Serum: blood drawn and allowed to clot at 37°C | Plasma collected with citrate/EDTA anticoagulant |
| Histopathology | Predominantly leukocytoclastic vasculitis (LCV) | Non-inflammatory microvascular thrombosis (thrombotic vasculopathy) |
| Common causes | Hepatitis C (HCV), lupus, plasma cell disorders (myeloma) | Solid-organ cancers, severe infection, primary (idiopathic) |
| Treatment response | Direct-acting antivirals (DAAs), rituximab, corticosteroids | Thrombolytics, anticoagulants, stanozolol |
Our Approach
At Haute-Derma, diagnosing cold-precipitating blood disorders requires strict sampling technique to avoid false-negative results:
- Strict 37°C Chain for Blood Collection and Centrifugation:
- Collection equipment and tubes (with anticoagulant for cryofibrinogen, without anticoagulant for cryoglobulins) are prewarmed to 37°C.
- The blood is kept at 37°C throughout transport and centrifugation.
- The serum or plasma is then stored at 4°C for 1–7 days to watch for precipitation and measure the cryocrit (%).
- Classifying Cryoglobulinemia (Brouet Classification):
- Type I (monoclonal): associated with B-cell or plasma cell malignancies (multiple myeloma, Waldenström macroglobulinemia).
- Types II and III (mixed): associated with HCV infection (more than 80%) and autoimmune disease.
- Multiple-Site Biopsy and Stains to Tell Them Apart:
- Determine whether the picture is LCV with nuclear dust or purely occlusive sclerosis/thrombosis.
- Comprehensive screening for underlying causes: hepatitis C serology (HCV RNA), hepatitis B, antinuclear antibodies (ANA), anti-SSA/SSB, and serum protein electrophoresis with immunofixation (SPEP/IFE).
Treatment at Haute-Derma
Our treatment plan aims to control the underlying cause of protein precipitation, shut down necrotizing vasculitis flares and heal ischemic ulcers:
- Systemic Treatment Targeting the Root Cause:
- Eliminating the causative virus: for HCV-related cryoglobulinemia, direct-acting antivirals (DAAs) clear the virus and bring about complete remission.
- Immune and B-cell suppression: high-dose corticosteroids combined with rituximab (an anti-CD20 antibody) shut down production of monoclonal/polyclonal cryoglobulins.
- Plasmapheresis: used as an emergency measure for severe flares causing extensive necrosis or life-threatening hyperviscosity.
- For cryofibrinogenemia: anticoagulants (warfarin, NOACs), fibrinolytic agents (stanozolol) or pentoxifylline.
- Specialized Necrotic Ulcer Care at Haute-Derma:
- Enzymatic debridement and moist wound healing: we avoid aggressive mechanical debridement in poorly perfused areas and use hydrogel and collagen dressings to soften the ulcer base and stimulate granulation tissue.
- Red LED (630 nm) combined with near-infrared LED (830 nm): dilates local vessels, improves microcirculation to the wound and eases peripheral nerve pain.
- Protection and Relapse Prevention:
- We advise patients to keep the whole body warm at all times, especially the hands and feet (gloves, warm socks, avoiding cold water and cold air conditioning).
- Preventing vasospasm: calcium channel blockers (nifedipine, amlodipine) help maintain peripheral microcirculation.
